Antisense strategies to inhibit restenosis

被引:22
作者
Lee, M [1 ]
Simon, AD [1 ]
Stein, CA [1 ]
Rabbani, LE [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1999年 / 9卷 / 05期
关键词
D O I
10.1089/oli.1.1999.9.487
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Restenosis after percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting remains a major clinical problem. Vascular smooth muscle cell (SMC) proliferation and migration from the arterial wall media into the intima are believed to play a critical role in the pathogenesis of restenosis. Several studies have demonstrated that phosphorothioate (PS) oligodeoxynucleotides targeted against genes involved in SMC proliferation inhibit in vitro SMC proliferation and migration. Moreover, PS oligodeoxynucleotides targeted against the genes c-myb, c-myc, cdc2 kinase, cdk2 kinase, and proliferating cell nuclear antigen (PCNA) when delivered adventitially or intraluminally inhibit in vivo neointimal formation after balloon injury in both the rat carotid and porcine coronary artery models. The inhibitory effects of these PS oligodeoxynucleotides may be the result of their suppression of migration of medial SMC rather than suppression of medial or intimal cell proliferation. Other studies have demonstrated the presence of the potent guanosine or G-quartet aptameric inhibitory effect of the PS oligodeoxynucleotides. Experiments with cytidine homopolymers such as S-dC28, which lack guanosines, reveal the presence of potent non-G-quartet, non-sequence-specific inhibitory effects on in vitro SMC proliferation, migration, and adhesion as well as in vivo neointimal formation after rat carotid artery balloon injury. This is owing to the avid binding of these PS oligodeoxynucleotides to the SMC mitogens and chemoattractants platelet-derived growth factor (PDGF) and basic fibroblast growth factor (bFGF). The extent to which hybridization-dependent antisense, G-quartet aptameric, or non-G-quartet, non-sequence-specific inhibitory effects occurs is the result of PS oligodeoxynucleotide sequence, length, and concentration. The 18-mer guanosine-rich PS oligodeoxynucleotide ZK10 is a more potent in vitro SMC proliferation inhibitor than S-dC28, although both compounds manifest comparable in vivo inhibitory effects on neointimal formation in the rat carotid artery model of balloon injury. PS oligodeoxynucleotides also possess non-sequence-specific immunomodulatory effects, including the induction of interferon-gamma and the unmethylated CpG moth, which exhibits numerous immunomodulatory effects. Novel strategies to inhibit restenosis include the development of E2F transcription decoys that inhibit several cell cycle regulatory genes and diminish neointimal lesion formation. In addition, antisense oligonucleotides targeted against the anti-apoptotic gene bcl-xL, which when transfected into the vessel wall inhibits bcl-xl expression, induce a five-fold increase in apoptotic SMC intimal cells, and effect a marked attenuation of in vivo lesion dimensions, thereby suggesting frank vascular lesion regression.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 51 条
[1]   SUPPRESSION OF NEOINTIMAL SMOOTH-MUSCLE CELL ACCUMULATION IN-VIVO BY ANTISENSE CDC2 AND CDK2 OLIGONUCLEOTIDES IN RAT CAROTID-ARTERY [J].
ABE, J ;
ZHOU, W ;
TAGUCHI, J ;
TAKUWA, N ;
MIKI, K ;
OKAZAKI, H ;
KUROKAWA, K ;
KUMADA, M ;
TAKUWA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (01) :16-24
[2]   ANTISENSE THERAPY FOR ANGIOPLASTY RESTENOSIS - SOME CRITICAL CONSIDERATIONS [J].
BENNETT, MR ;
SCHWARTZ, SM .
CIRCULATION, 1995, 92 (07) :1981-1993
[3]   INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN-VITRO AND IN-VIVO BY C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
BENNETT, MR ;
ANGLIN, S ;
MCEWAN, JR ;
JAGOE, R ;
NEWBY, AC ;
EVAN, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :820-828
[4]   Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery - Dissecting the mechanism of action [J].
Bennett, MR ;
Lindner, V ;
DeBlois, D ;
Reidy, MA ;
Schwartz, SM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2326-2332
[5]   INHIBITORY EFFECTS OF ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETING C-MYC MESSENGER-RNA ON SMOOTH-MUSCLE CELL-PROLIFERATION AND MIGRATION [J].
BIRO, S ;
FU, YM ;
YU, ZX ;
EPSTEIN, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :654-658
[6]  
BROWN KE, 1992, J BIOL CHEM, V267, P4625
[7]   THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM [J].
BURGESS, TL ;
FISHER, EF ;
ROSS, SL ;
BREADY, JV ;
QIAN, YX ;
BAYEWITCH, LA ;
COHEN, AM ;
HERRERA, CJ ;
HU, SSF ;
KRAMER, TB ;
LOTT, FD ;
MARTIN, FH ;
PIERCE, GF ;
SIMONET, L ;
FARRELL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4051-4055
[8]  
DRACHMAN DE, 1999, APPL ANTISENSE THERA, P153
[9]   ANTIPROLIFERATIVE EFFECTS OF A C-MYC ANTISENSE OLIGONUCLEOTIDE ON HUMAN ARTERIAL SMOOTH-MUSCLE CELLS [J].
EBBECKE, M ;
UNTERBERG, C ;
BUCHWALD, A ;
STOHR, S ;
WIEGAND, V .
BASIC RESEARCH IN CARDIOLOGY, 1992, 87 (06) :585-591
[10]   A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].
FISCHMAN, DL ;
LEON, MB ;
BAIM, DS ;
SCHATZ, RA ;
SAVAGE, MP ;
PENN, I ;
DETRE, K ;
VELTRI, L ;
RICCI, D ;
NOBUYOSHI, M ;
CLEMAN, M ;
HEUSER, R ;
ALMOND, D ;
TEIRSTEIN, PS ;
FISH, RD ;
COLOMBO, A ;
BRINKER, J ;
MOSES, J ;
SHAKNOVICH, A ;
HIRSHFELD, J ;
BAILEY, S ;
ELLIS, S ;
RAKE, R ;
GOLDBERG, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501